These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1617965)
1. Serum nickel, copper and zinc in Norplant users. Ismail AA; Toppozada M; Zahran M; Ghanem I; Kholeif A Contraception; 1992 Jun; 45(6):561-72. PubMed ID: 1617965 [TBL] [Abstract][Full Text] [Related]
2. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels. Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202 [TBL] [Abstract][Full Text] [Related]
3. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017 [TBL] [Abstract][Full Text] [Related]
4. Serum nickel concentration in normal menstrual cycle and after combined contraceptive pill. Nayel S; Zahran M; Gawad AA; Mokhtar A; Gawish S; el-Tabbakh G Contraception; 1986 Oct; 34(4):395-401. PubMed ID: 3780237 [TBL] [Abstract][Full Text] [Related]
5. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs. Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675 [TBL] [Abstract][Full Text] [Related]
6. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users. Lau TM; Witjaksono J; Affandi B; Rogers PA Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364 [TBL] [Abstract][Full Text] [Related]
8. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users. Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753 [TBL] [Abstract][Full Text] [Related]
9. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants. Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139 [TBL] [Abstract][Full Text] [Related]
10. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771 [TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant). Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775 [TBL] [Abstract][Full Text] [Related]
12. Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant. Faundes A; Tejada AS; Brache V; Alvarez F Contraception; 1987 Feb; 35(2):189-96. PubMed ID: 3109804 [TBL] [Abstract][Full Text] [Related]
14. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception. Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774 [TBL] [Abstract][Full Text] [Related]
15. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants. Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058 [TBL] [Abstract][Full Text] [Related]
16. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Goodger AM; Rogers PA; Affandi B Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724 [TBL] [Abstract][Full Text] [Related]
17. NORPLANT contraceptive implants advancing. Segal SJ Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797 [TBL] [Abstract][Full Text] [Related]
18. Norplant-2 subdermal contraceptive system: experience in Taiwan. Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598 [TBL] [Abstract][Full Text] [Related]
19. Experience with NORPLANT in Egypt. Shaaban MM Ann Med; 1993 Apr; 25(2):167-9. PubMed ID: 8489755 [TBL] [Abstract][Full Text] [Related]
20. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus. Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]